TET2 and chronic myelomonocytic leukemia: TET2 mutations are highly prevalent in cases of aCML, CMML and MDS/MPN unclassifiable (41%, 62% and 26% respectively) as shown by several authors, although these studies have not looked into cases with isolated i(17q) abnormality in particular [14–25].